Interleukin-9 Deletion Relieves Vascular Dysfunction and Decreases Blood Pressure via the STAT3 Pathway in Angiotensin II-Treated Mice

Table 2

Clinical characteristics of patients with or without hypertension.

Characteristics	Control	Hypertension	value
Elderly (, %)	22 (44.0)	32 (40.0)	0.716
Male (, %)	32 (64.0)	53 (66.3)	0.851
Smoked (, %)	14 (28.0)	35 (43.8)	0.094
Drinking (, %)	11 (22.0)	25 (31.3)	0.315
(, %)	29 (58.0)	61 (76.3)	0.033
Family history (, %)	18 (36.0)	39 (48.8)	0.204
Hyperlipidemia (, %)	11 (22.0)	24 (30.0)	0.417
T2DM (, %)	1 (2.0)	3 (3.8)	0.999
Age (years)	57 (39, 71)	58 (43, 71)	0.712
BMI (kg/m^2)	25.2 (23.8, 27.2)	25.7 (24.2, 27.9)	0.672
SBP (mmHg)	120 (109, 130)	164 (149, 173)	<0.001
DBP (mmHg)	75 (69, 83)	101 (89, 109)	<0.001
HR (bpm)	72 (63, 79)	74 (66, 81)	0.414
CREA (μmol/L)	75 (66, 89)	75 (63, 85)	0.816
Glu (mmol/L)	5.3 (4.6, 5.7)	5.5 (4.8, 5.9)	0.398
TC (mmol/L)	4.6 (4.1, 5.1)	4.5 (4.0, 5.0)	0.664
TG (mmol/L)	1.4 (1.1, 2.1)	1.4 (1.1, 2.0)	0.782
HDL-C (mmol/L)	1.4 (0.9, 1.6)	1.3 (1.0, 1.6)	0.279
LDL-C (mmol/L)	2.4 (1.9, 2.9)	2.3 (1.8, 2.7)	0.198
Medications (, %)
ACEI/ARB	0 (0)	55 (68.8)	<0.001
β-Blockers	0 (0)	20 (25.0)	<0.001
CCB	0 (0)	60 (75.0)	<0.001
Diuretic	0 (0)	21 (26.3)	<0.001

BMI: body mass index; T2DM: type 2 diabetes mellitus; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; CREA: creatinine; Glu: fasting glucose; TC: total cholesterol; TG: total triglycerides; HDL-C: high-density lipoprotein cholesterol; HDL-C: low-density lipoprotein cholesterol; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blockers.